Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep401 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Efficacy of a groupal lifestyle intervention programme for weight loss in obesity

Cayon-Blanco Manuel , Cepero Dolores , Lopez-Perez M Jose , Garcia-Garcia-Doncel Lourdes , Baena-Nieto Maria Gloria

Introduction: Obesity is one of the most important problems worldwide in recent times. Groupal lifestyle intervention programmes are efficacious in the management of obesity. While exercise and healthy dietary habits have consistently been shown to improve various metabolic markers, adherence to these behaviors is low and methods that increase adherence to health behaviors are needed.Objective: The primary objective of this study is to evaluate the effec...

ea0090ep1030 | Thyroid | ECE2023

Primary Thyroid Lymphoma: Clinical Course vs High Suvmax in Fdg-Pet

Lopes-Pinto Mariana , Aparicio David , Paula Ricca Lacerda Nobre M Caetano Ema , Dolores Lopez-Presa Maria , Joao Bugalho Maria

Introduction: Primary thyroid lymphomas (PTL) account for 5% of all thyroid malignancies. Treatment and prognosis depend on tumor subtype. Contrasting with diffuse large B-cell lymphomas (DLBCL), that have an aggressive clinical course and higher maximum standardized uptake value (SUVmax) in Fluorine-18-fluorodeoxyglucose positron emission tomography (FDG-PET), thyroid extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue (MALT) usually show an indolen...

ea0056p66 | Adrenal cortex (to include Cushing's) | ECE2018

Evaluation of cardiometabolic profile of patients submitted to unilateral adrenalectomy

Castro Raquel Vaz de , Costa Cristiana , Matos Tania , Quadros Catarina , Lopez Dolores , Vale Sonia do , Bugalho Maria Joao

Background and aims: It is known that unilateral adrenalectomy as treatment for autonomous secreting adrenal cortex adenomas effectively reduces cardiometabolic risk. Non-autonomous secreting adenomas are not expected to increase cardiometabolic risk, but this has not been thoroughly explored.We evaluated the blood pressure and glycemic profile before and after unilateral adrenalectomy for both autonomous and non-autonomous secreting adrenal cortex adenomas.<p class="abste...

ea0041gp199 | Thyroid - Translational &amp; Clinical | ECE2016

Does maternal thyroid autoimmunity predict adverse pregnancy outcomes?

Sastre-Marcos Julia , Val-Zaballos Florentino , Ruiz-Gines Miguel Angel , Olivar-Azuara Monica , Agudo-Macazaga Mercedes , Fontelles-Alcover Roser , Maldonado Dolores , Lopez-Lopez Jose

Background: Previous studies of association between maternal thyroid autoimmunity and adverse pregnancy outcomes have produced inconsistent results.Objective: To examine whether thyroid autoimmunity detected at first trimester screening is predictive of a range of adverse obstetric and fetal outcomes.Patients and methods: We studied 438 women with singleton pregnancies who underwent first trimester screening test between June and J...

ea0016p591 | Paediatric endocrinology | ECE2008

Prevalence of obesity and metabolic syndrome among Spanish adolescents

Garcia-Garcia Emilio , Galera Rafael , Gomez-Bueno Sara , Gamez Maria-Dolores , Lopez-Ruzafa Encarnacion , Ruiz-Sanchez Ana , Oliva Patricia , Martin Manuel , Vazquez Angeles , Bonillo Antonio

Purposes: To report the prevalence of obesity, metabolic syndrome (MS) and its related components among adolescents living in the city of Almería (south of Spain). To examine the distribution of HOMA-IR (homeostasis model assessment of insulin resistance).Methods: A total of 373 subjects attending secundary school (aged 12–17 years) participated in a community-based cross-sectional survey. IOTF (International Obesity Task Force) criteria were u...

ea0056p138 | Endocrine tumours and neoplasia | ECE2018

Evaluation of neurofibromatosis type 1 and gastroenteropancreatic neuroendocrine tumors.

Percovich Juan Carlos , Atencia Jose , Garcia Rogelio , Sambo Marcel , Blanco Montserrat , Rotger Amanda , Lopez Dolores , Olmedilla Yoko , Picallo Maria , Velez Marian , Agreda Javier , Brox Noemi , Monereo Susana

Introduction: Neurofibromatosis type 1 (NF1) is an autosomal dominant condition with an incidence of 1 in 2600 to 3000 individuals. Patients with this disorder are characterized by multiple neurofibromas, caf-au-lait macules, axillary freckling, optic gliomas, iris hamartomas, and skeletal abnormalities. Overall risk of developing neoplasms is approximately 2 to 4-fold higher in patients with NF1, with a risk of malignancy estimated between 5 and 15%. Endocrinopathies are some...